Bundle

Pharma’s 2026 hit list: The White Album

20 January 2026

The pharmaceutical industry is poised for a strong year, despite rising global fragmentation – much like the Beatles’ White Album, a masterpiece born amid internal discord

Download

In this bundle

Healthcare

Pharma's 2026 hit list: The White Album

Pharma's 2026 White Album will tell you all you need to know about the year ahead

Healthcare

Money (That's What I Want): 2026 is the year of truth for Trump’s…

2026 is set to bring more stability for the pharmaceutical industry, which is good for business

Healthcare

Hello, Goodbye: Europe loses ground as China becomes powerhouse of innovation

US President Trump's reforms may provide Europe a golden opportunity

Healthcare

Come Together: Pharma M&A set to accelerate in 2026

2026 should be a good year for pharma M&A as a result of reduced uncertainty and the looming patent cliff

With a Little Help From My Friends: the importance of CDMOs will continue to…

We expect strong CDMO growth in 2026, driven by geopolitical fragmentation and regional manufacturing consolidation

Penny Lane: US and Europe stay reliant on generic medicines from Asia

Western dependence on Asian generics will remain in 2026, in spite of growing national security measures

Weight Loss Drugs US Trump Tariffs R&D Pharmaceuticals Manufacturing M&A Innovation Geopolitics Europe EU Critical Medicines Act Covid China CDMOs

Content Disclaimer

This publication has been prepared by ING solely for information purposes irrespective of a particular user's means, financial situation or investment objectives. The information does not constitute investment recommendation, and nor is it investment, legal or tax advice or an offer or solicitation to purchase or sell any financial instrument.
Read more

Download